Crestview Clinical Laboratory LLC

Crestview Clinical Laboratory LLC was paid $2.15M by Medicaid between Jan 2018 and Jan 2023, across 40 billing codes. Its largest line is U0003, Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r — 71% of everything it billed.

Compared with peers

Next to other Clinical Medical Laboratory providers in California

Rank by total paid#144 of 561

Median peer was paid$222K

This provider vs. median9.7×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Box 24A · Dates of service

Paid by month

Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider

By year, as a table

Year	Claims	Paid
2018	8,236	$12K
2019	6,257	$25K
2020	9,120	$217K
2021	40,010	$1.22M
2022	22,472	$662K
2023	374	$14K

Box 24 · Service lines

What it billed for

Code	Service	Share	Claims	Bene. records	Paid
U0003	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r	71%	27,142	18,819	$1.52M
G2023	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source	18%	24,333	17,138	$378K
U0005	Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, cdc or non-cdc, making use of high throughput technologies, completed within 2 calendar days from date of specimen collection (list separately in addition to either hcpcs code u0003 or u0004) as described by cms-2020-01-r2	7.4%	15,103	10,771	$158K
85025	Blood count; complete (CBC), automated, and automated differential WBC count	<1%	3,810	3,182	$19K
80053	Comprehensive metabolic panel	<1%	2,127	2,073	$9K
83021		<1%	1,046	1,039	$7K
80061	Lipid panel	<1%	1,769	1,761	$7K
86409		<1%	250	246	$7K
87502	Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets	<1%	89	81	$6K
84443	Thyroid stimulating hormone (TSH)	<1%	699	689	$6K
85730		<1%	969	963	$5K
86408		<1%	267	265	$5K

28 more codes

85610		<1%	1,015	$3K
82306	Vitamin D; 25 hydroxy, includes fraction(s), if performed	<1%	410	$3K
87634		<1%	87	$3K
80164		<1%	244	$3K
80048	Basic metabolic panel (calcium, ionized)	<1%	347	$2K
84703		<1%	314	$2K
84439		<1%	179	$1K
81001		<1%	1,164	$1K
G2024	Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]) from an individual in a snf or by a laboratory on behalf of a hha, any specimen source	<1%	38	$760.00
82728		<1%	58	$716.20
80178		<1%	83	$488.87
83735		<1%	82	$458.92
83721		<1%	1,200	$442.27
83550		<1%	67	$429.66
83540		<1%	69	$367.90
99000		<1%	274	$342.53
81000		<1%	125	$242.18
81005		<1%	1,167	$118.03
36415	Collection of venous blood by venipuncture	<1%	1,553	$96.60
86677		<1%	25	$66.11
84481		<1%	12	$45.10
82274		<1%	12	$38.58
85651		<1%	49	$19.00
83036	Hemoglobin; glycosylated (A1C)	<1%	12	$7.69
P9604	Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge	0%	181	$0.00
84550		0%	12	$0.00
80050	General health panel	0%	69	$0.00
84436		0%	17	$0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialNGUYEN, JUSTIN (PRESIDENT)